These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1527 related items for PubMed ID: 25802423
1. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review. Gómez-Outes A, Lecumberri R, Suárez-Gea ML, Terleira-Fernández AI, Monreal M, Vargas-Castrillón E. J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):490-500. PubMed ID: 25802423 [Abstract] [Full Text] [Related]
2. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review. Wu C, Alotaibi GS, Alsaleh K, Sean McMurtry M. Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174 [Abstract] [Full Text] [Related]
4. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer. Kahale LA, Hakoum MB, Tsolakian IG, Matar CF, Terrenato I, Sperati F, Barba M, Yosuico VE, Schünemann H, Akl EA. Cochrane Database Syst Rev; 2018 Jun 19; 6(6):CD006650. PubMed ID: 29920657 [Abstract] [Full Text] [Related]
5. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses. Almutairi AR, Zhou L, Gellad WF, Lee JK, Slack MK, Martin JR, Lo-Ciganic WH. Clin Ther; 2017 Jul 19; 39(7):1456-1478.e36. PubMed ID: 28668628 [Abstract] [Full Text] [Related]
6. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach. Rollins BM, Silva MA, Donovan JL, Kanaan AO. Clin Ther; 2014 Oct 01; 36(10):1454-64.e3. PubMed ID: 25092394 [Abstract] [Full Text] [Related]
7. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism. Robertson L, Yeoh SE, Ramli A. Cochrane Database Syst Rev; 2017 Dec 15; 12(12):CD011088. PubMed ID: 29244199 [Abstract] [Full Text] [Related]
8. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis. Marik PE, Cavallazzi R. PLoS One; 2015 Dec 15; 10(11):e0143252. PubMed ID: 26587983 [Abstract] [Full Text] [Related]
9. Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis. Sobieraj DM, Coleman CI, Pasupuleti V, Deshpande A, Kaw R, Hernandez AV. Thromb Res; 2015 May 15; 135(5):888-96. PubMed ID: 25795564 [Abstract] [Full Text] [Related]
10. Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis. Alhousani M, Malik SU, Abu-Hashyeh A, Poznanski NJ, Al-Hasan S, Roth DF, Alsharedi M, Mustafa B. Thromb Res; 2021 Feb 15; 198():103-114. PubMed ID: 33310644 [Abstract] [Full Text] [Related]
11. Anticoagulant selection for patients with VTE-Evidence from a systematic literature review of network meta-analyses. Cohen AT, Berger SE, Milenković D, Hill NR, Lister S. Pharmacol Res; 2019 May 15; 143():166-177. PubMed ID: 30905806 [Abstract] [Full Text] [Related]
12. Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials. Kakkos SK, Kirkilesis GI, Tsolakis IA. Eur J Vasc Endovasc Surg; 2014 Nov 15; 48(5):565-75. PubMed ID: 24951377 [Abstract] [Full Text] [Related]
13. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review. Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Terleira-Fernández AI, Vargas-Castrillón E. Vasc Health Risk Manag; 2014 Nov 15; 10():627-39. PubMed ID: 25404858 [Abstract] [Full Text] [Related]
14. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Carrier M, Le Gal G, Wells PS, Rodger MA. Ann Intern Med; 2010 May 04; 152(9):578-89. PubMed ID: 20439576 [Abstract] [Full Text] [Related]
15. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism. Lecumberri R, Alfonso A, Jiménez D, Fernández Capitán C, Prandoni P, Wells PS, Vidal G, Barillari G, Monreal M, RIETE investigators. Thromb Haemost; 2013 Oct 04; 110(4):834-43. PubMed ID: 23846721 [Abstract] [Full Text] [Related]
16. Safety ad efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism. Imberti D, Pomero F, Benedetti R, Fenoglio L. Intern Emerg Med; 2016 Oct 04; 11(7):895-900. PubMed ID: 27550399 [Abstract] [Full Text] [Related]
17. Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis. Elsebaie MAT, van Es N, Langston A, Büller HR, Gaddh M. J Thromb Haemost; 2019 Apr 04; 17(4):645-656. PubMed ID: 30690830 [Abstract] [Full Text] [Related]
18. Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis. Gómez-Outes A, Terleira-Fernández AI, Lecumberri R, Suárez-Gea ML, Vargas-Castrillón E. Thromb Res; 2014 Oct 04; 134(4):774-82. PubMed ID: 25037495 [Abstract] [Full Text] [Related]
19. Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens. Trujillo-Santos J, Di Micco P, Dentali F, Douketis J, Díaz-Peromingo JA, Núñez MJ, Cañas I, Mastroiacovo D, Saraiva de Sousa M, Monreal M, RIETE Investigators. Thromb Haemost; 2017 Jan 26; 117(2):382-389. PubMed ID: 27786333 [Abstract] [Full Text] [Related]
20. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer. Kirkilesis GI, Kakkos SK, Tsolakis IA. Eur J Vasc Endovasc Surg; 2019 May 26; 57(5):685-701. PubMed ID: 31097186 [Abstract] [Full Text] [Related] Page: [Next] [New Search]